SYRE Change in Working Capital
Spyre Therapeutics Inc · Change in Working Capital
SYRE Change in Working Capital
Latest reported-$5.01Mperiod ending
SYRE Change in Working Capital ($26.00K → -$5.01M)
Annual change in working capital
High-resolution chart · PNG
SYRE change in working capital history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Change in Working Capital (USD) |
|---|---|
| -5,934,000 | |
| -4,534,000 | |
| -5,206,000 | |
| -5,503,000 | |
| 1,833,000 | |
| -2,540,000 | |
| 7,104,000 | |
| 7,201,000 | |
| -198,000 | |
| 1,450,000 | |
| -1,333,000 | |
| 26,000 |